HomeBiotech

Biotech

Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals

Life Sciences Times - July 17, 2026

Biotech

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

Life Sciences Times - July 17, 2026

Biotech

Syntis Bio Reports Positive Initial Phase 1/1b Data for Obesity Drug SYNT-101

Life Sciences Times - July 16, 2026

Biotech

Foundation Medicine Launches Initiative on Cancer Biomarker Test Quality

Life Sciences Times - July 16, 2026

Biotech

Alnylam Advances RNAi Neuroscience Programs in Alzheimer’s and Related Diseases

Life Sciences Times - July 15, 2026

Biotech

Life Sciences Leaders Optimistic About Funding Prospects but Cautious About Growth Outlook, New Research Finds

Life Sciences Times - December 23, 2020 0

Biotech

Amgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency

Life Sciences Times - December 22, 2020 0

Biotech

AstraZeneca’s Fasenra gets DCGI nod for asthma treatment in India

Life Sciences Times - December 22, 2020 0

Biotech

Amgen Awards Two Biotech Start-Ups With Golden Ticket To LabCentral

Life Sciences Times - December 18, 2020 0

Biotech

Allterum Therapeutics completes Series Seed offering

Life Sciences Times - December 18, 2020 0

Biotech

Ginkgo Bioworks Acquires Biotechnology Startup Novogy

Life Sciences Times - December 17, 2020 0

Biotech

Virios Therapeutics Announces Pricing of Initial Public Offering

Life Sciences Times - December 17, 2020 0

Biotech

Outgoing MassBio President and CEO Robert Coughlin to Join JLL to Grow Life Sciences Industry Practice

Life Sciences Times - December 16, 2020 0

Biotech

Revance Therapeutics to Relocate Global Headquarters to Nashville From Silicon Valley

Life Sciences Times - December 16, 2020 0

Biotech

Aditum Bio Announces Formation of Third Company, Anteris Bio Anteris Bio Aimed at Treating Renal Diseases

Life Sciences Times - December 15, 2020 0

Biotech

FDA grants IO Biotech products breakthrough therapy designation

Life Sciences Times - December 15, 2020 0

Biotech

Massachusetts Biotech Council President and CEO Robert Coughlin to Step Down

Life Sciences Times - December 14, 2020 0

1...99100101 Page 100 of 101

Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals

July 17, 2026

Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials

July 17, 2026

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

July 17, 2026

Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration

July 17, 2026

Biotech

Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

Syntis Bio Reports Positive Initial Phase 1/1b Data for Obesity Drug SYNT-101

Foundation Medicine Launches Initiative on Cancer Biomarker Test Quality

Alnylam Advances RNAi Neuroscience Programs in Alzheimer’s and Related Diseases

Most Read

Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals

Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration

EDITOR PICKS

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

Syntis Bio Reports Positive Initial Phase 1/1b Data for Obesity Drug SYNT-101

AdvanCell Raises $315 Million to Advance Targeted Alpha Cancer Therapies

THIS WEEK'S STORIES

Universal Brain Receives FDA Clearance for Rapid Brain-Function Assessment System

Celea Therapeutics Doses First Patient in Phase 3 IPF Trial

Immuto Scientific Identifies Potential Targets in Drug-Resistant Lung Cancer

POPULAR CATEGORY

ABOUT US

FOLLOW US